Biogen strongly believes that collaboration with healthcare professionals is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the same time, we believe that these interactions must be conducted openly and transparently.

As a member of EFPIA (the European Federation of Pharmaceutical Industries and Associations), Biogen is proud to endorse and uphold the EFPIA Disclosure Code. In line with the code, Biogen has been collecting all payments and contributions made to Healthcare Professionals and Organizations since January 2015.

Biogen International GmbH is committed to work with patient organizations and supporting their efforts to improve the lives of their members and raise awareness of serious medical conditions. We are aligned in enhancing patient advocacy and supporting medical research for the discovery of effective therapies with a focus on serious neurological, autoimmune and rare diseases.

In 2015, Biogen International GmbH provided funding to the patient organizations listed below in support of several important projects.

Patient organization Project Amount of support
Alzheimer Europe Sponsoring of projects for disease awareness in Europe; supporting Clinical Trial Watch and the Annual Conference 2016. 20.000 EUR
EMSP - European MS Platform
Core funding to support patient educational activities; Spring Conference 2015; MS Nurse Pro; Under Pressure Project; Believe & Achieve Project; MS Barometer; Online Communication and Disease Awareness.
190.000 EUR
EURORDIS Biogen is a member of the EURODIS Round Table of Companies. 15.000 EUR
IAVE - International Association for Volunteer Effort
Sponsoring of workshop and European conference on corporate volunteering – sharing best practices.
7.500 CHF
MSIF - MS International Federation Funding of World MS Day 2015 and of stronger capacity building programs for MS organizations globally – focusing on the Arab Region and Latin America. 107.600 GBP
Shift.ms Funding of a pilot project for an online space for recently diagnosed people with MS. 32.965 GBP